Auddia Announces Reverse Stock Split

Auddia Announces Reverse Stock Split

BOULDER, CO, March 27, 2025 - PRISM MediaWire - Auddia Inc., (“Auddia” or the “Company”) (NASDAQ: AUUD, AUUDW), an AI first technology company that has built a proprietary AI platform for audio identification and classification to reinvent how consumers engage with...

Aclarion Announces Reverse Stock Split

Aclarion Announces Reverse Stock Split

BROOMFIELD, Colo., March 26, 2025 - PRISM MediaWire - Aclarion, Inc., (“Aclarion” or the “Company”) (NASDAQ: ACON, ACONW), a healthcare technology company that is leveraging biomarkers and proprietary augmented intelligence algorithms to help physicians identify the...

Oncocyte Reports Successful 2024; Sets Stage for 2025 Catalysts

Oncocyte Reports Successful 2024; Sets Stage for 2025 Catalysts

Q4 2024 revenue of $1.5 million in pharma services; full year revenue of $1.9 million GraftAssure RUO assay launched July 2024 Signed strategic partner and investor, Bio-Rad Laboratories Fully funded clinical kitted product development with $50+ million in equity...